BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1323323)

  • 1. The impact of abdominal computerized tomography on the pretreatment staging and prognosis of small cell lung cancer.
    Hirsch FR; Osterlind K; Jensen LI; Thomsen C; Peters K; Jensen F; Hansen HH
    Ann Oncol; 1992 Jun; 3(6):469-74. PubMed ID: 1323323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal CT in the staging of small-cell carcinoma of the lung: incidence of metastases and effect on prognosis.
    Mirvis SE; Whitley NO; Aisner J; Moody M; Whitacre M; Whitley JE
    AJR Am J Roentgenol; 1987 May; 148(5):845-7. PubMed ID: 3034008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography of the brain, liver, and upper abdomen in the staging of small cell carcinoma of the lung.
    Poon PY; Feld R; Evans WK; Ege G; Yeoh JL; McLoughlin ML
    J Comput Assist Tomogr; 1982 Oct; 6(5):963-5. PubMed ID: 6292272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
    Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
    J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous abdominal ultrasonography in the staging of lung cancer.
    Bakke PS; Taule M; Lillo E; Melgren G; Magnussen IJ; Halvorsen OJ
    Thorax; 1997 Mar; 52(3):276-80. PubMed ID: 9093346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal computed tomography in small cell lung cancer: assessment of extent of disease and response to therapy.
    Ihde DC; Dunnick NR; Johnston-Early A; Bunn PA; Cohen MH; Minna JD
    Cancer; 1982 Apr; 49(7):1485-90. PubMed ID: 6277467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on prognosis of bone marrow infiltration detected by magnetic resonance imaging in small cell lung cancer.
    Seto T; Imamura F; Kuriyama K; Funakoshi T; Gotoh H; Nakayama T; Nakamura S; Horai T
    Eur J Cancer; 1997 Dec; 33(14):2333-7. PubMed ID: 9616277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal CT in the staging of small cell carcinoma of the lung.
    Whitley NO; Mirvis SE
    Crit Rev Diagn Imaging; 1989; 29(2):103-16. PubMed ID: 2540935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
    Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
    J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
    Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
    J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?
    Micke P; Faldum A; Metz T; Beeh KM; Bittinger F; Hengstler JG; Buhl R
    Lung Cancer; 2002 Sep; 37(3):271-6. PubMed ID: 12234695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].
    Remiszewski P; Roszkowski-Sliz K; Wiatr E; Roszkowska-Sliz B; Zych J; Kurzyna M; Jodkiewicz Z; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2003; 71(3-4):139-47. PubMed ID: 14587419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
    Kut V; Spies W; Spies S; Gooding W; Argiris A
    Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal CT in lung carcinoma.
    Hall FM
    AJR Am J Roentgenol; 1980 May; 134(5):1092-3. PubMed ID: 6245572
    [No Abstract]   [Full Text] [Related]  

  • 16. Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decision making.
    Chauvin F; Trillet V; Court-Fortune I; Velay B; Mazoyer G; Girodet B; Gormand F; Rebattu P; Cordier JF
    Chest; 1992 Aug; 102(2):497-502. PubMed ID: 1322812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer.
    Sheehan RG; Balaban EP; Cox JV; Frenkel EP
    J Clin Oncol; 1990 Dec; 8(12):2047-53. PubMed ID: 2172474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer.
    Benitah N; Yeh BM; Qayyum A; Williams G; Breiman RS; Coakley FV
    Radiology; 2005 May; 235(2):517-22. PubMed ID: 15858092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound tumor staging of bronchial cancer].
    Schulz G; Nürnberg D
    Z Arztl Fortbild (Jena); 1992 May; 86(9):445-9. PubMed ID: 1318620
    [No Abstract]   [Full Text] [Related]  

  • 20. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
    Lee YJ; Cho A; Cho BC; Yun M; Kim SK; Chang J; Moon JW; Park IK; Choi HJ; Kim JH
    Clin Cancer Res; 2009 Apr; 15(7):2426-32. PubMed ID: 19318478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.